{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:29:41Z","timestamp":1762100981091},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,9,10]],"date-time":"2009-09-10T00:00:00Z","timestamp":1252540800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Science Inc"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s11916-009-0062-5","type":"journal-article","created":{"date-parts":[[2009,9,9]],"date-time":"2009-09-09T06:07:17Z","timestamp":1252476437000},"page":"381-385","source":"Crossref","is-referenced-by-count":13,"title":["Hormonal therapies for menstrual migraine"],"prefix":"10.1007","volume":"13","author":[{"given":"Anne H.","family":"Calhoun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,9,10]]},"reference":[{"key":"62_CR1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1046\/j.1526-4610.2001.041007646.x","volume":"41","author":"R.B. Lipton","year":"2001","unstructured":"Lipton RB, Stewart WF, Diamond S, et al.: Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001, 41:646\u2013657.","journal-title":"Headache"},{"key":"62_CR2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11916-001-0089-8","volume":"5","author":"C.L. Lay","year":"2001","unstructured":"Lay CL, Mascellino AM: Menstrual migraine: diagnosis and treatment. Curr Pain Headache Rep 2001, 5:195\u2013199.","journal-title":"Curr Pain Headache Rep"},{"key":"62_CR3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11940-004-0006-7","volume":"6","author":"L.K. Mannix","year":"2004","unstructured":"Mannix LK, Calhoun AH: Menstrual migraine. Curr Treat Options Neurol 2004, 6:489\u2013498.","journal-title":"Curr Treat Options Neurol"},{"key":"62_CR4","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/j.1526-4610.2005.00242.x","volume":"45","author":"V.T. Martin","year":"2005","unstructured":"Martin VT, Wernke S, Mandell K, et al.: Defining the relationship between ovarian hormones and migraine headache. Headache 2005, 45:1190\u20131201.","journal-title":"Headache"},{"key":"62_CR5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1468-2982.2003.00516.x","volume":"23","author":"E.G. Courturier","year":"2003","unstructured":"Courturier EG, Bombof MA, Neven AK, van Duijn NP: Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment. Cephalalgia 2003, 23:302\u2013308.","journal-title":"Cephalalgia"},{"key":"62_CR6","first-page":"38","volume":"29","author":"A. Calhoun","year":"2004","unstructured":"Calhoun A: Four hypotheses for understanding menstrual migraine. Female Patient 2004, 29:38\u201344.","journal-title":"Female Patient"},{"key":"62_CR7","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/01.SMJ.0000129924.15619.D9","volume":"97","author":"A.H. Calhoun","year":"2004","unstructured":"Calhoun AH: A novel specific prophylaxis for menstrual-associated migraine. South Med J 2004, 97:819\u2013822.","journal-title":"South Med J"},{"key":"62_CR8","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1526-4610.2008.01176.x","volume":"48","author":"A. Calhoun","year":"2008","unstructured":"Calhoun A, Ford S: Elimination of menstrual-related migraine beneficially impacts chronification and medication overuse. Headache 2008, 48:1186\u20131193.","journal-title":"Headache"},{"key":"62_CR9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1526-4610.2007.00650.x","volume":"47","author":"P. Sulak","year":"2007","unstructured":"Sulak P, Willis S, Kuehl T, et al.: Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval. Headache 2007, 47:27\u201337.","journal-title":"Headache"},{"key":"62_CR10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.contraception.2006.06.003","volume":"74","author":"D.F. Archer","year":"2006","unstructured":"Archer DF: Menstrual-cycle-related symptoms: a review of the rationale for continuous use of oral contraceptives. Contraception 2006, 74:359\u2013366.","journal-title":"Contraception"},{"key":"62_CR11","doi-asserted-by":"crossref","unstructured":"Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet 1996, 348:498\u2013505.","DOI":"10.1016\/S0140-6736(95)12393-8"},{"key":"62_CR12","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/archinte.164.7.741","volume":"164","author":"W.S. Chan","year":"2004","unstructured":"Chan WS, Ray J, Wai EK, et al.: Risk of stroke in women exposed to low-dose oral contraceptives: a critical evaluation of the evidence. Arch Intern Med 2004, 164:741\u2013747.","journal-title":"Arch Intern Med"},{"key":"62_CR13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/bmj.38302.504063.8F","volume":"330","author":"M. Etminan","year":"2005","unstructured":"Etminan M, Takkouche B, Isorna FC, Samii A: Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 2005, 330:63.","journal-title":"BMJ"},{"key":"62_CR14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM199607043350102","volume":"335","author":"D.B. Petitti","year":"1996","unstructured":"Petitti DB, Sidney S, Bernstein A, et al.: Stroke in users of low-dose oral contraceptives. N Engl J Med 1996, 335:8\u201315.","journal-title":"N Engl J Med"},{"key":"62_CR15","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1161\/01.STR.29.11.2277","volume":"29","author":"S.M. Schwartz","year":"1998","unstructured":"Schwartz SM, Petitti DB, Siscovick DS, et al.: Stroke and use of low-dose oral contraceptives in young women: a pooled analysis of two US studies. Stroke 1998, 29:2277\u20132284.","journal-title":"Stroke"},{"key":"62_CR16","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/jnnp.73.6.747","volume":"73","author":"M. Donaghy","year":"2002","unstructured":"Donaghy M, Chang CL, Poulter N: Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age. J Neurol Neurosurg Psychiatry 2002, 73:747\u2013750.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"62_CR17","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1161\/STROKEAHA.107.488395","volume":"38","author":"L.R. MacClellan","year":"2007","unstructured":"MacClellan LR, Giles W, Cole J, et al.: Probable migraine with visual aura and risk of ischemic stroke: the stroke prevention in young women study. Stroke 2007, 38:2438\u20132445.","journal-title":"Stroke"},{"key":"62_CR18","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1136\/bmj.293.6561.1540","volume":"293","author":"B. Lignieres de","year":"1986","unstructured":"de Lignieres B, Vincens M, Mauvais-Jarvis P, et al.: Prevention of menstrual migraine by percutaneous oestradiol. Br Med J (Clin Res Ed) 1986, 293:1540.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"62_CR19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/09513598809023619","volume":"2","author":"L. Dennerstein","year":"1988","unstructured":"Dennerstein L, Morse C, Burrows G, et al.: Menstrual migraine: a double-blind trial of percutaneous estradiol. Gynecol Endocrinol 1988, 2:113\u2013120.","journal-title":"Gynecol Endocrinol"},{"key":"62_CR20","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1212\/01.wnl.0000249114.52802.55","volume":"67","author":"E.A. MacGregor","year":"2006","unstructured":"MacGregor EA, Frith A, Ellis J, et al.: Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study. Neurology 2006, 67:2159\u20132163.","journal-title":"Neurology"},{"key":"62_CR21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1526-4610.1994.hed3402103.x","volume":"34","author":"M.G. Smits","year":"1994","unstructured":"Smits MG, van der Meer YG, Pfeil JP, et al.: Perimenstrual migraine: effect of Estraderm TTS and the value of contingent negative variation and exteroceptive temporalis muscle suppression test. Headache 1994, 34:103\u2013106.","journal-title":"Headache"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-009-0062-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11916-009-0062-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-009-0062-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T09:57:08Z","timestamp":1710583028000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11916-009-0062-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,10]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["62"],"URL":"https:\/\/doi.org\/10.1007\/s11916-009-0062-5","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,10]]}}}